Resistell

The fastest and most extensible Antibiotic Susceptibility Testing (AST) Platform

Resistell was founded in 2018, is headquartered in Basel, Switzerland, lists 11–50 employees, and has $13.1M in recorded funding across 2 rounds.

Headquarters
Basel
Employees
11–50
Founded
2018
Business Model
B2B
Total Funding
$13.1M
Last Round
$9.2M Series BDec 2022
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 6 investors for this company. The full record is or through the API.

About

Resistell is a Swiss medtech company based in Basel that has commercialized a nanomotion-based rapid antibiotic susceptibility testing (AST) device, technology invented at EPFL's Laboratory of Physics of Living Matter. Founded in 2018 as a spin-off from the École Polytechnique Fédérale de Lausanne, Resistell's diagnostic platform helps clinicians identify effective antibiotics for bacterial infections such as sepsis faster than traditional culture-based methods, addressing the growing threat of antimicrobial resistance (AMR).

Summary

Resistell is a Biotech company based in Basel, Switzerland, founded in 2018. It lists 11–50 employees. It has raised $13.1M in total across 2 rounds, most recently a $9.2M Series B round in Dec 2022. Investors include OCCIDENT, European Innovation Council Fund and TRUMPF Venture.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BDec 2022
$9.2M

Sign up to see all 2 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Resistell on Indexed.vc
<a href="https://indexed.vc/companies/resistell"><img src="https://indexed.vc/api/badge/company/resistell" alt="Resistell on Indexed.vc" width="260" height="76" /></a>